ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0660

Improving the Gout Flare Chart Review Using Linked Claims-EHR Data

Kazuki Yoshida, Tianrun Cai, Lily G. Bessette, Erin Kim, Su Been Lee, Luke E. Zabotka, Alec Sun, Jun Liu, DH Solomon, Katherine Liao and Seoyoung Kim, Brigham and Women's Hospital, Boston, MA

Meeting: ACR Convergence 2021

Keywords: Administrative Data, Bioinformatics, EMR, gout

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 7, 2021

Title: Metabolic & Crystal Arthropathies – Basic & Clinical Science Poster I (0660–0682)

Session Type: Poster Session B

Session Time: 8:30AM-10:30AM

Background/Purpose: Recurrent gout flares are the most crucial outcome in studies of gout treatment. However, gout flares is challenging to identify in a large population because it is episodic with limited data to distinguish encounters for a gout flare vs routine follow-up for gout. The objective of this study was to determine whether integrating information extracted from the narrative notes from the electronic health record (EHR) data using natural language processing (NLP) can improve the efficiency for identifying gout glares over claims data alone.

Methods: The study population was defined by first linking Medicare claims data (2007-16) with EHR data from two tertiary care centers. Subjects with age≥65, ≥1 gout ICD9/10 code, and initiated the urate-lowering therapy (ULT; allopurinol or febuxostat) were included in the study. Chart reviews were performed on a random sample of the study population to create a gold standard set of notes describing gout flare. A list of terms related to gout flare was created informed by the chart review (Table 1). Terms were further mapped to concepts as defined by the Unified Medical Language System (UMLS). Narrative notes for all subjects were processed using NLP to identify all notes containing terms/concepts related to gout flare. Claims data were also used to segment notes by time period in two ways (claims time filter): (1) identify notes within the 12-month baseline before date of ULT initiation through ULT discontinuation; (2) notes occurring in months with ≥1 ICD9/10 gout code from claims within (1). We tested whether NLP and the application of temporally based claims-based rules could improve the prevalence of notes describing gout flares compared to ICD alone.

Results: A random sample of 69 patients with 10,845 notes was examined. NLP concepts representing signs and symptoms of a gout flare, e.g. redness, severe pain, differed the most among notes describing gout flares compared to those that were not (Table 2). After processing notes using NLP, 708 (6.5%) of 10,845 notes had concepts relevant to gout flare (Table 3); of the 708 notes, 24.4% described a gout flare. Applying claims time filter 1 alone to the 10,845 notes selected 2,198 (20%), of which 271 also had relevant NLP concepts. Claims time filter 2 selected 691 notes (6.4%), of which 169 also had relevant NLP concepts. Using a combination of NLP and claims time filter 2, which gave notes in months where an ICD9/10 gout code was used (nested within the 12-month baseline and during ULT use), resulted in 54% prevalence of gout flares among the selected notes.

Conclusion: Certain NLP concepts may be useful in discriminating notes describing gout flare among a population of subjects with gout on ULT therapy. The combination of NLP as well as the use of claims data with a time component, e.g., segmented by months, can assist in selecting relevant notes describing a gout flare. Together, these provide data for the development of a gout flare phenotyping algorithm with month-level precision.


Disclosures: K. Yoshida, None; T. Cai, None; L. Bessette, None; E. Kim, None; S. Lee, None; L. Zabotka, None; A. Sun, None; J. Liu, None; D. Solomon, Abbvie, 5, Amgen, 5, Genentech, 5; K. Liao, None; S. Kim, AbbVie, 5, Roche, 5, Pfizer, 5, Bristol-Myers Squibb, 5.

To cite this abstract in AMA style:

Yoshida K, Cai T, Bessette L, Kim E, Lee S, Zabotka L, Sun A, Liu J, Solomon D, Liao K, Kim S. Improving the Gout Flare Chart Review Using Linked Claims-EHR Data [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/improving-the-gout-flare-chart-review-using-linked-claims-ehr-data/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/improving-the-gout-flare-chart-review-using-linked-claims-ehr-data/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology